Decision details

National Drug Strategy – From Harm to Hope

Decision Maker: Executive

Decision status: Recommendations Approved

Is Key decision?: Yes

Is subject to call in?: Yes

Purpose:

The National Drug Strategy From Harm to Hope was published in December 2021. In June 2022 guidance for local delivery partners was published which included a requirement for a new Combating Drugs Partnership to be established to ensure that local areas meet all of the requirements set out in the strategy.  The purpose of this report is to ensure that the Executive are in agreement that a Berkshire East Combating Drugs is established.

Decision:

1          That the geographical footprint of the Combatting Drugs Partnership be based on a Berkshire East Partnership due to the co-terminosity with the Integrated Care Partnership and Public Health functions.

 

2          That the appointment of Stuart Lines as the Senior Responsible Officer who will represent the Combatting Drugs Partnership and account for local delivery and performance to central government be endorsed.

 

3          That a temporary partnership post be developed to support the establishment of the Berkshire East Combatting Drugs Partnership, the development of the terms of reference, undertake a needs assessment for Berkshire East and develop a strategy on how the partnership will deliver against the priorities in the national drug strategy

 

4          That a Local Drug Strategy Delivery Partnership be established to oversee the delivery of the local drug strategy and report on progress to the Berkshire East Combatting Drugs Partnership.

 

5          That the Leader be requested to appoint the member representative to the Combatting Drugs Partnership.

Reasons for the decision:

The strategy requires local areas in England to have a strong partnership that brings together all the relevant organisations and key individuals.  The Combatting Drugs Partnership will be responsible for reporting directly into central government and will have an appointed Senior Responsible Officer.

 

Whilst the Combatting Drugs Partnership will be responsible for overseeing delivery against the priorities of the drug strategy, it will not be a decision making partnership.  A local delivery partnership that can fulfil that role and report progress to the Berkshire East Combatting Drugs Partnership will also be required.

Alternative options considered:

The Guidance for local delivery partners make it clear that an entirely new Combatting Drugs Partnership needs to be established in local areas so there are no alternatives to consider.

Interests and Nature of Interests Declared:

None.

Reason Key: Affects more than 1 ward;

Wards Affected: (All Wards);

Financial Impact: Failing to establish a Combating Drugs Partnership could result in the Supplementary Substance Misuse Treatment and Recovery Grant being withheld

Declarations: None.

Subject to Urgent Proceedings: No.

Making Representations: In writing to the Executive Director: People

Other reasons / organisations consulted

A number of organisations have been consulted in respect of the requirement to establish a Combating Drug Partnership to meet the requirements of the National Drug Strategy; From Harm to Hope. The consultations were undertaken by way of Teams meetings and e-mails.

Consultees

Elected members in Bracknell Forest, Slough and Windsor

Contact: Tony Dwyer, Assistant Director: Mental Health and Out of Hours Email: tony.dwyer@bracknell-forest.gov.uk Tel: 823333, Grainne Siggins, Executive Director People Email: grainne.siggins@bracknell-forest.gov.uk.

Report author: Tony Dwyer

Publication date: 29/09/2022

Date of decision: 29/09/2022

Decided at meeting: 29/09/2022 - Executive

Effective from: 07/10/2022

Accompanying Documents: